These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 6384571

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Current biochemical conceptions of mental disorders. I. Biogenic amines in the pathogenesis of schizophrenia].
    Anokhina IP, Gamaleia NB.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1096-1105. PubMed ID: 384732
    [No Abstract] [Full Text] [Related]

  • 3. Neuropsychopharmacology of monoamines and their regulatory enzymes.
    Lipton MA.
    Adv Biochem Psychopharmacol; 1974; 12(0):443-54. PubMed ID: 4153941
    [No Abstract] [Full Text] [Related]

  • 4. Norepinephrine reward pathways: role of self-stimulation, memory consolidation, and schizophrenia.
    Stein L.
    Nebr Symp Motiv; 1975; 22():113-59. PubMed ID: 1688
    [No Abstract] [Full Text] [Related]

  • 5. [Biochemistry of schizophrenia and mechanism of action of neuroleptics].
    Loo H, Cuche H, Sechter D.
    Sem Hop; 1982 Dec 02; 58(44):2565-72. PubMed ID: 6130604
    [Abstract] [Full Text] [Related]

  • 6. Semidehydroascorbate as a product of the enzymic conversion of dopamine to norepinephrine. Coupling of semidehydroascorbate reductase to dopamine-beta-hydroxylase.
    Diliberto EJ, Allen PL.
    Mol Pharmacol; 1980 May 02; 17(3):421-6. PubMed ID: 7393218
    [No Abstract] [Full Text] [Related]

  • 7. Toward hypotheses for a biochemical component in the vulnerability to schizophrenia.
    Kety SS.
    Semin Psychiatry; 1972 Aug 02; 4(3):233-8. PubMed ID: 4155537
    [No Abstract] [Full Text] [Related]

  • 8. [Effects of antibodies to dopamine-beta-monooxygenase on the level of catecholamines in the brain].
    Pogosian AS, Boiadzhian AS, Karagezian KG, Aĭvazian VA, Movsesian AV.
    Biull Eksp Biol Med; 1991 Aug 02; 112(8):133-4. PubMed ID: 1786369
    [No Abstract] [Full Text] [Related]

  • 9. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE, Wise CD, Potkin SG, Zalcman S, Phelps BH, Lovenberg W, Wyatt RJ.
    Biol Psychiatry; 1980 Dec 02; 15(6):895-907. PubMed ID: 7459411
    [Abstract] [Full Text] [Related]

  • 10. Possible etiology of schizophrenia: progressive damage to the noradrenergic reward system by endogenous 6-hydroxydopamine.
    Stein L, Wise CD.
    Res Publ Assoc Res Nerv Ment Dis; 1972 Dec 02; 50():298-314. PubMed ID: 5071537
    [No Abstract] [Full Text] [Related]

  • 11. Quantitation of 3,4-dihydroxyphenylacetaldehyde and 3, 4-dihydroxyphenylglycolaldehyde, the monoamine oxidase metabolites of dopamine and noradrenaline, in human tissues by microcolumn high-performance liquid chromatography.
    Burke WJ, Chung HD, Li SW.
    Anal Biochem; 1999 Aug 15; 273(1):111-6. PubMed ID: 10452806
    [Abstract] [Full Text] [Related]

  • 12. Biochemical aspects of schizophrenia.
    Lewis ME.
    Essays Neurochem Neuropharmacol; 1980 Aug 15; 4():1-67. PubMed ID: 6104597
    [No Abstract] [Full Text] [Related]

  • 13. Neurotransmitter-related enzymes in the major psychiatric disorders: II. MAO and DBH in schizophrenia.
    Wyatt RJ, Murphy DL.
    Res Publ Assoc Res Nerv Ment Dis; 1975 Aug 15; 54():289-97. PubMed ID: 769116
    [No Abstract] [Full Text] [Related]

  • 14. Prolactin levels in schizophrenia: relation to platelet monoamine oxidase, plasma amine oxidase, plasma dopamine-beta-hydroxylase, and erythrocyte catechol-O-methyltransferase activity.
    Baron M, Levitt M, Asnis L, Fein M.
    Biol Psychiatry; 1983 May 15; 18(5):579-82. PubMed ID: 6860731
    [No Abstract] [Full Text] [Related]

  • 15. Behavioral and neurobiological changes in C57BL/6 mice exposed to cuprizone.
    Xu H, Yang HJ, Zhang Y, Clough R, Browning R, Li XM.
    Behav Neurosci; 2009 Apr 15; 123(2):418-29. PubMed ID: 19331464
    [Abstract] [Full Text] [Related]

  • 16. [Inadequacy of the monoamine oxidase system--the probable pathogenetic factor in schizophrenia (review)].
    Kolpakov VG.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974 Apr 15; 74(8):1254-63. PubMed ID: 4278558
    [No Abstract] [Full Text] [Related]

  • 17. Effect of amphetamine on brain catecholamines, brain beta-endorphin, serum prolactin, catechol-O-methyltransferase and monoamine oxidase of various organs in the rat.
    Agarwal DP, Hoo JJ, Tjaden A, Nishigaki I, Beckermann WJ, Pahnke V, Goedde HW.
    Arzneimittelforschung; 1985 Apr 15; 35(11):1639-42. PubMed ID: 2936351
    [Abstract] [Full Text] [Related]

  • 18. [Determination of dopamine-beta-hydroxylase (DBH) and monoamine oxidase (MAO) activities in platelets and plasma in schizophrenic, maniac-depressive and neurotic patients].
    Xavier Vieira R, Azevedo M, Polónio P, Manso C.
    Acta Med Port; 1986 Apr 15; 7(1):45-8. PubMed ID: 3728081
    [No Abstract] [Full Text] [Related]

  • 19. [Neuroleptics, monoamine oxidase inhibitors and dopamine beta hydroxylase inhibitors: their actions and interactions].
    Vetulani J.
    Postepy Hig Med Dosw; 1973 Apr 15; 27(6):725-80. PubMed ID: 4589208
    [No Abstract] [Full Text] [Related]

  • 20. [Findings of biochemical research on schizophrenia (author's transl)].
    Ackenheil M, Hippius H, Matussek N.
    Nervenarzt; 1978 Nov 15; 49(11):634-49. PubMed ID: 31575
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.